31602-63-8

Usage

Uses

Used in Pharmaceutical Research:
C-(2H-TETRAZOL-5-YL)-METHYLAMINE is used as a building block in pharmaceutical research for its potential applications in the development of new drugs.
Used in Organic Synthesis:
C-(2H-TETRAZOL-5-YL)-METHYLAMINE is used as a key intermediate in organic synthesis for the preparation of various chemical compounds.
Used in Central Nervous System Stimulation:
C-(2H-TETRAZOL-5-YL)-METHYLAMINE is used as a potential central nervous system stimulant for its ability to enhance cognitive function and alertness.
Used in Antibacterial Applications:
C-(2H-TETRAZOL-5-YL)-METHYLAMINE is used as an antibiotic agent for its potential to combat bacterial infections.
Used in Antiparasitic Applications:
C-(2H-TETRAZOL-5-YL)-METHYLAMINE is used as an antiparasitic agent for its potential to treat parasitic infections.

InChI:InChI=1/C2H5N5/c3-1-2-4-6-7-5-2/h1,3H2,(H,4,5,6,7)

Upstream product

• 108723-22-4 N-(1H-tetrazol-5-ylmethyl)-acetamide 
• 114841-44-0 2-((1H-tetrazol-5-yl)methyl)isoindoline-1,3-dione 
• 107269-64-7 C-(1-benzyl-1H-tetrazol-5-yl)-methylamine; hydrochloride 
• 118764-13-9 1H-1,2,3,4-tetrazol-5-ylmethanamine hydrochloride 
• 55408-11-2 5-chloromethyl-1H-tetrazole 

Downstream Products

• 112273-70-8 N-((1H-tetrazol-5-yl)methyl)benzamide 
• 109942-80-5 N-phenyl-N'-(1H-tetrazol-5-ylmethyl)-urea 
• 108723-22-4 N-(1H-tetrazol-5-ylmethyl)-acetamide 
• 342612-74-2 Pyrazine-2-carboxylic acid ((S)-1-{(1S,2S)-1-[(S)-2-cyclohexyl-1-((S)-1-{hydroxy-[(1H-tetrazol-5-ylmethyl)-carbamoyl]-methyl}-propylcarbamoyl)-ethylcarbamoyl]-2-methyl-butylcarbamoyl}-3-methyl-butyl)-amide 
• 863253-31-0 Pyrazine-2-carboxylic acid ((S)-1-{(1S,2S)-1-[(S)-2-cyclohexyl-1-((S)-3,3-difluoro-1-{hydroxy-[(1H-tetrazol-5-ylmethyl)-carbamoyl]-methyl}-propylcarbamoyl)-ethylcarbamoyl]-2-methyl-butylcarbamoyl}-3-methyl-butyl)-amide 
• 727396-62-5 3-(1H-tetrazol-5-ylmethylaminocarbonylmethyl)-benzaldehyde 
• 115894-70-7 tert-butyl ((2H-tetrazol-5-yl)methyl)carbamate 
• 1236537-78-2 4-{(1S)-1-[(7-bromo-5-methyl-1-benzothien-3-yl)(4-chlorophenyl)methyl]butyl}-N-(2H-tetrazol-5-ylmethyl)benzamide 
• 1344707-31-8 (R/S)-N-((1H-tetrazol-5-yl)methyl)-2-hydroxy-2-(4-(5-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-1,2,4-oxadiazol-3-yl)phenyl)acetamide 
• 1257301-88-4 C₁₇H₁₅F₃N₈ 

Relevant academic research and scientific papers

Synthesis and preliminary evaluation of amiloride analogs as inhibitors of the urokinase-type plasminogen activator (uPA)

A known side-activity of the oral potassium-sparing diuretic drug amiloride is inhibition of the enzyme urokinase-type plasminogen activator (uPA, K i = 7 μM), a promising anticancer target. Several studies have demonstrated significant antitum

SUBSTITUTED-QUINOXALINE-TYPE-PIPERIDINE COMPOUNDS AND THE USES THEREOF

The invention relates to Substituted-Quinoxaline-Type Piperidine Compounds, compositions comprising an effective amount of a Substituted-Quinoxaline-Type Piperidine Compound and methods to treat or prevent a condition, such as pain, comprising administeri

Synthesis of tetrazole analogues of amino acids using Fmoc chemistry: isolation of amino free tetrazoles and their incorporation into peptides

An efficient synthesis of tetrazole analogues of amino acids starting from Nα-Fmoc amino acid in a three-step protocol is reported. The free amino tetrazoles were obtained in good yields and with excellent purity after removal of the Fmoc group

A Methanoditetrazolo-tetrazecine from 5-(Chloromethyl)tetrazole and Hexamethylenetetramine

In contrast to N-substituted 5-(chloromethyl)tetrazoles (1; R = alkyl, aryl), the parent compound 1 (R = H) reacts with hexamethylenetetramine to give the methanoditetrazolo-tetrazecine 4, a rather unusual system.This compound which is also produced on reaction of 7 with formaldehyde occurs in the (6RS,13RS) form.